UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korean firms struggle to develop antidiabetic generic
Korean pharmaceutical companies are competing fiercely to develop the gener...
by Lee Hye-seon
|
2017-03-06 10:40
라인
Ministry recalls 2 drugs with quality problems
The Ministry of Food and Drug Safety said Friday that it would recall Belvi...
by Lee Hye-seon
|
2017-03-06 07:30
라인
Drug makers jittery about illegal lobby scandal
The domestic pharmaceutical industry is keeping a close watch on the suspec...
by Park Gi-taek
|
2017-03-03 18:24
라인
Medytox’s sales hit record high last year
Medytox, a local biopharmaceutical company, is growing rapidly with major p...
by Lee Hye-seon
|
2017-02-28 13:55
라인
Korean generic drugs to increase market share in Vietnam
The Korean generic drugs will likely increase their share in the Vietnamese...
by Lee Hye-seon
|
2017-02-28 11:08
라인
Health insurance agency hit by kickback scandal
Two officials at Health Insurance Review and Assessment Service (HIRA) are ...
by Lee Hye-seon
|
2017-02-27 18:57
라인
Secrets to technology export?
Dong-A ST made headlines in December by exporting “DA-4501,” a candidate su...
by Lee Hye-seon
|
2017-02-24 11:03
라인
Korea Inc. goes all out to lead bio, pharmaceutical industries
The Korean government and businesses are going to great length to promote b...
by Park Gi-taek and Lee Hye-seon
|
2017-02-22 09:00
라인
Korean Pharmaceuticals Trying to Avoid the Patents of Betmiga PR
Korean pharmaceuticals are desperate to find ways to avoid the patent right...
by Lee Hye-seon
|
2017-02-17 09:17
라인
Daewoong Pharmaceutical Recorded Sales Less than 800billion won Last Year
Daewoong Pharmaceutical failed to achieve 800billion won in sales in 2016.D...
by Lee Hye-seon
|
2017-02-13 10:07
라인
AZ ‘Vimovo’ Always Loses No.1 to Naxozole
‘Vimovo (ingredient name: Naproxen+Esomeprazole magnesium trihydrate) made ...
by Lee Hye-seon
|
2017-02-10 15:46
라인
Hanmi Pharm Dropping Out of a 1trillion Sales Club, Is it Possible to Take Off Again?
As expected, Hanmi Pharm didn’t achieve 1trillion won in sales in 2016.Hanm...
by Lee Hye-seon
|
2017-02-10 08:42
라인
Janssen’s Ground-breaking MDR-TB Drug ‘SIRTURO’ Achieves International Prix Galien Award
Janssen Pharmaceuticals Inc, a Pharmaceutical Companies of Johnson & Johnso...
by Constance Williams
|
2017-02-09 09:41
라인
Abbott Korea Stops Importing ‘KLARICID Dry Syrup’
The Ministry of Food and Drug Safety (MFDS) issued an executive order to st...
by Lee Hye-seon
|
2017-02-08 16:37
라인
How Schizophrenia is Looming Across Asia-Pacific Countries, Including the Gangnam Murder
The Janssen Pharmaceutical Companies of Johnson & Johnson has been treating...
by Constance Williams
|
2017-02-08 08:29
라인
‘Rebellion’ of a Generic Leaving the World No.1 Treatment for Epilepsy, Vimpat Tab behind
The generic of oral medication Vimpat Tab (ingredient name: Lacosamide) to ...
by Lee Hye-seon
|
2017-02-06 11:26
라인
Sanofi Voluntarily Recalls Insulin Apidra
Sanofi-Aventis Korea voluntarily recalls diabetics treatment drugs such as ...
by Lee Hye-seon
|
2017-02-06 09:18
라인
The Know-how to Detect Fake Drugs for Erectile Dysfunction
Koreans are much interested in various kinds of healthy food and stamina-re...
by Lee Hye-seon
|
2017-02-03 08:14
라인
“It’s More Dangerous Not to Prescribe Statin Because of the Possible Outbreak of Diabetes”
Experts released the statement about Statin that has caused the possible ou...
by Park Gi-taek
|
2017-01-20 08:52
라인
CJ Healthcare’s Value is Allegedly Worth of 1trillion won, Why doesn’t the Company Undertake IPO?
The CJ Healthcare’s plan to secure money for investment through listing reached a deadlock. CJ Healthcare selected NH IN...
by Lee Hye-seon
|
2017-01-18 10:04
-
이전
121
122
123
124
125
126
127
128
129
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top